Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Tachycardia, Supraventricular 1Heart Failure 1Cardiotoxicity 1Atrial Fibrillation 1Arrhythmias, Cardiac 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gonadal Steroid Hormones × Clear all
NCT07412873 2026-02-17

PROVIDENCE

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Not yet recruiting
120 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03243604 2018-10-18

ARBITRAGE

Groupe Hospitalier Pitie-Salpetriere

Completed
1,717 enrolled

Arrhythmias, Cardiac, Atrial Fibrillation, Heart Failure, Tachycardia, Supraventricular, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡